Trends in Patient-Recalled Targets for Cardiovascular Risk Factors in Ambulatory US Adults With Diabetes Mellitus (from National Health and Nutrition Examination Survey) - 31/12/21
Doi : 10.1016/j.amjcard.2021.10.019
Kartik Gupta, MD a, Renato C. Viacava, MD a, Vardhmaan Jain, MD b, Tanya Singh Kakar, MD c, Michelle Jesse, PhD a, d, Salim S. Virani, MD e, f, g
a Division of General Internal Medicine, Department of Medicine, Henry Ford Hospital, Detroit, Michigan
b Department of Medicine, Cleveland Clinic, Cleveland, Ohio
c Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan
d Transplant Institute, Henry Ford Health System, Detroit, Michigan
e Section of Cardiology and Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas
f Health Policy, Quality & Informatics Program, Health Services Research and Development Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
g Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
Le texte complet de cet article est disponible en PDF.
Plan
© 2021
Publié par Elsevier Masson SAS.
Vol 164
P. 143-145 - février 2022 Retour au numéro
Article précédent
- Direct Oral Anticoagulants in Cardiac Amyloidosis–Associated Heart Failure and Atrial Fibrillation
- Amgad Mentias, Paulino Alvarez, Pulkit Chaudhury, Michael Nakhla, Rohit Moudgil, Mohamad Kanj, Mazen Hanna, Milind Y. Desai
- Corrigendum to ‘Impact of Patient Prosthesis Mismatch on the Outcome of Transcatheter Pulmonic Valve Implantation’ [The American Journal of Cardiology 151C (2021) 93-99]
- Daiji Takajo, Thomas J Forbes, Daisuke Kobayashi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?